Invivyd (IVVD) Expected to Announce Quarterly Earnings on Thursday

Invivyd (NASDAQ:IVVD - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $34.45 million for the quarter.

Invivyd (NASDAQ:IVVD - Get Free Report) last posted its earnings results on Thursday, March 20th. The company reported ($0.15) earnings per share for the quarter, topping analysts' consensus estimates of ($0.25) by $0.10. The firm had revenue of $13.80 million for the quarter, compared to analysts' expectations of $13.57 million. On average, analysts expect Invivyd to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Invivyd Trading Down 1.1 %

Invivyd stock traded down $0.01 on Tuesday, hitting $0.57. 110,289 shares of the stock traded hands, compared to its average volume of 4,274,882. Invivyd has a 1 year low of $0.35 and a 1 year high of $2.74. The firm has a market cap of $68.26 million, a P/E ratio of -0.29 and a beta of 0.40. The business's fifty day simple moving average is $0.69 and its 200 day simple moving average is $0.77.

Wall Street Analysts Forecast Growth

IVVD has been the topic of a number of analyst reports. D. Boral Capital reissued a "buy" rating and issued a $9.00 price target on shares of Invivyd in a research report on Thursday, March 20th. HC Wainwright reissued a "buy" rating and issued a $10.00 target price on shares of Invivyd in a report on Wednesday, March 26th.

About Invivyd

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.